Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Autoimmune Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 1941483

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1941483

Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Product, By Test, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Autoimmune Disease Diagnostics Market Summary

The global autoimmune disease diagnostics market size was estimated at USD 6.07 billion in 2025 and is projected to reach USD 9.58 billion by 2033, growing at a CAGR of 5.84% from 2026 to 2033. The increasing prevalence of autoimmune disorders such as type 1 diabetes in newborn babies, coupled with the demand for rapid diagnostics, is the key driver accentuating growth.

In addition, there is an increasing focus on investments and funding for research related to autoimmune diseases, which further propels market growth. Furthermore, developing countries offer untapped opportunities for market expansion, presenting significant growth prospects in the years to come.

The establishment of technological advancements and the expansion of lab automation rates are anticipated to boost market growth. Clinicians are implementing advanced technology to conduct several tests at the same time with faster and more precise results.

Autoimmune diseases are a group of more than 100 chronic, debilitating conditions that affect approximately 3% of the US population. Some of the most common autoimmune diseases include obesity, cardiovascular diseases, type 2 diabetes mellitus, and all cancers. Thus, genetic factors, environmental influences, specific hormones, and susceptibility to certain infections are key contributors to the rising prevalence of autoimmune diseases globally. According to an article published by the National Health Council in September 2024, autoimmune diseases affect approximately 50 million Americans, and women account for 80% of this number. Given the inherent complexity involved in diagnosing these conditions, this figure is likely understated. More concerning is the fact that autoimmune diseases are approaching epidemic proportions, with several studies indicating annual growth rates in the range of 3%-12%.

An increasing rate of novel technological advancements and the corresponding emergence of laboratory automation technologies significantly contribute to market expansion. This trend is driven by the growing adoption of advanced technologies among clinicians, enabling them to conduct a wide range of tests while achieving faster and more accurate results. For instance, in January 2025, Werfen received FDA clearance for Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) Reagents. These assays enhance the accuracy of antiphospholipid syndrome (APS) diagnosis, addressing a significant unmet need in the diagnosis of autoimmune diseases.

In addition, the implementation of government initiatives across economies supports market developments. Work by organizations such as the Autoimmunity Centers of Excellence (ACE), the Cooperative Study Group for Autoimmune Disease Prevention (CSGADP), and the North American Rheumatoid Arthritis Consortium (NARAC) contributes to market growth by creating awareness among patients and healthcare professionals regarding proper diagnosis and treatment protocols.

The involvement of organizations such as the Autoimmunity Centers of Excellence, Cooperative Study Group for Autoimmune Disease Prevention, and North American Rheumatoid Arthritis Consortium in educating patients and healthcare professionals about proper diagnosis and treatment is anticipated to have a positive impact on market dynamics, as it promotes awareness and early intervention in autoimmune diseases. This, in turn, is expected to drive the growth of the autoimmune disease diagnostics market. Besides, favorable government initiatives aimed at increasing access to diagnostic tests, improving disease management and reducing healthcare costs, among other factors, are also expected to boost market growth during the forecast period.

Global Autoimmune Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global autoimmune disease diagnostics market report based on type, product, test, end use, and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Systemic autoimmune disease diagnostics
    • Rheumatoid arthritis
    • Ankylosing spondylitis
    • Systemic lupus erythematosus (SLE)
    • Others
  • Localized autoimmune disease diagnostics
    • Multiple sclerosis
    • Type 1 diabetes
    • Hashimoto's Thyroiditis
    • Idiopathic thrombocytopenic purpura
    • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Consumables and Assays
  • Test Outlook (Revenue, USD Million, 2021 - 2033)
  • Antinuclear antibody tests
  • Autoantibody tests
  • C-reactive Protein (CRP)
  • Complete blood count (CBC)
  • Urinalysis
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-292-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Test segment
      • 1.1.1.4. End use segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Test Snapshot
  • 2.3. Product and End use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Presence of research funding programs
      • 3.2.1.2. Presence of favorable government initiatives
      • 3.2.1.3. Growing patient awareness levels
      • 3.2.1.4. Technological innovation in the form of lab automation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Slow diagnostic result turnaround times and lack of skilled healthcare practitioner
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

  • 4.1. Autoimmune Disease Diagnostics Market: Type Movement Analysis
  • 4.2. Systemic Autoimmune Disease Diagnostics
    • 4.2.1. Systemic Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.2.2. Rheumatoid Arthritis Diagnostics
      • 4.2.2.1. Rheumatoid Arthritis Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.2.3. Ankylosing Spondylitis Diagnostics
      • 4.2.3.1. Ankylosing Spondylitis Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.2.4. Systemic Lupus Erythematosus (SLE) Diagnostics
      • 4.2.4.1. Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.2.5. Other Systemic Autoimmune Disease Diagnostics
      • 4.2.5.1. Other Systemic Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • 4.3. Localized Disease Diagnostics
    • 4.3.1. Localized Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.3.2. Multiple sclerosis diagnostics
      • 4.3.2.1. Multiple sclerosis diagnostics Market, 2021 - 2033 (USD Million)
    • 4.3.3. Type 1 Diabetes Diagnostics
      • 4.3.3.1. Type 1 Diabetes Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.3.4. Hashimoto's Thyroiditis Diagnostics
      • 4.3.4.1. Hashimoto's Thyroiditis Diagnostics Market, 2021 - 2033 (USD Million)
    • 4.3.5. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics
      • 4.3.5.1. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics Market, 2021 - 2033 (USD Million)
    • 4.3.6. Other Localized Autoimmune Disease Diagnostics
      • 4.3.6.1. Other Localized Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Autoimmune Disease Diagnostics Market: Product Movement Analysis
  • 5.2. Instruments
    • 5.2.1. Instruments Market, 2021 - 2033 (USD Million)
  • 5.3. Consumables and Assays
    • 5.3.1. Consumables and Assays Market, 2021 - 2033 (USD Million)

Chapter 6. Test Business Analysis

  • 6.1. Autoimmune Disease Diagnostics Market: Test Movement Analysis
  • 6.2. Antinuclear Antibody Tests
    • 6.2.1. Antinuclear Antibody Tests Market, 2021 - 2033 (USD Million)
  • 6.3. Autoantibody Tests
    • 6.3.1. Autoantibody Tests Market, 2021 - 2033 (USD Million)
  • 6.4. C-reactive Protein (CRP)
    • 6.4.1. C-Reactive Protein (CRP) Market, 2021 - 2033 (USD Million)
  • 6.5. Complete Blood Count (CBC)
    • 6.5.1. Complete Blood Count (CBC) Market, 2021 - 2033 (USD Million)
  • 6.6. Urinalysis
    • 6.6.1. Urinalysis Market, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Autoimmune Disease Diagnostics Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Hospitals Market, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Centers
    • 7.3.1. Diagnostic Centers Market, 2021 - 2033 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Autoimmune Disease Diagnostics Market Share By Region, 2024 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. U.S. Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Canada Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.2.5. Mexico
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Target Disease Prevalence
      • 8.2.5.3. Competitive Scenario
      • 8.2.5.4. Regulatory Framework
      • 8.2.5.5. Mexico Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. UK Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Germany Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. France Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Italy Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Spain Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Sweden Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Norway Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.10. Denmark
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Denmark Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Japan Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. China Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. India Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Australia Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Thailand Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. South Korea Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Brazil Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. SWOT Analysis
    • 8.6.2. Middle East and Africa Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. South Africa Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Saudi Arabia Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. UAE Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Kuwait Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Siemens Healthineers AG
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Abbott
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Beckman Coulter, Inc.
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Danaher Corporation
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Quest Diagnostics
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. EUROIMMUN Medizinische Labordiagnostika AG
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Nova Diagnostics Pte Ltd.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. BIOMERIEUX
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Hemagen Diagnostics, Inc.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
Show more
Product Code: 978-1-68038-292-1

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviation
  • TABLE 3 Global Autoimmune Disease Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • TABLE 4 Global Autoimmune Disease Diagnostics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 5 Global Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 6 Global Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 7 Global Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 8 North America Autoimmune Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • TABLE 9 North America Autoimmune Disease Diagnostics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 10 North America Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 11 North America Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 12 North America Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 13 U.S. Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 14 U.S. Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 15 U.S. Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 16 U.S. Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 17 Canada Autoimmune Disease Diagnostics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 18 Canada Autoimmune Disease Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • TABLE 19 Canada Autoimmune Disease Diagnostics Market, by Test, 2021 - 2033 (USD Million)
  • TABLE 20 Canada Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 21 Mexico Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 22 Mexico Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 23 Mexico Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 24 Mexico Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 25 Europe Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • TABLE 26 Europe Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 27 Europe Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 28 Europe Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 29 Europe Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 30 UK Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 31 UK Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 32 UK Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 33 UK Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 34 Germany Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 35 Germany Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 36 Germany Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 37 Germany Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 38 France Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 39 France Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 40 France Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 41 France Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 42 Italy Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 43 Italy Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 44 Italy Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 45 Italy Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 46 Spain Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 47 Spain Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 48 Spain Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 49 Spain Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 50 Sweden Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 51 Sweden Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 52 Sweden Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 53 Sweden Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 54 Norway Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 55 Norway Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 56 Norway Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 57 Norway Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 58 Denmark Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 59 Denmark Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 60 Denmark Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 61 Denmark Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 62 Asia Pacific Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • TABLE 63 Asia Pacific Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 64 Asia Pacific Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 65 Asia Pacific Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 66 Asia Pacific Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 67 Japan Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 68 Japan Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 69 Japan Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 70 Japan Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 71 China Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 72 China Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 73 China Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 74 China Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 75 India Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 76 India Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 77 India Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 78 India Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 79 Australia Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 80 Australia Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 81 Australia Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 82 Australia Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 83 Thailand Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 84 Thailand Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 85 Thailand Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 86 Thailand Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 87 South Korea Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 88 South Korea Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 89 South Korea Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 90 South Korea Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 91 Latin America Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • TABLE 92 Latin America Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 93 Latin America Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 94 Latin America Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 95 Latin America Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 96 Brazil Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 97 Brazil Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 98 Brazil Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 99 Brazil Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 100 Argentina Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 101 Argentina Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 102 Argentina Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 103 Argentina Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 104 Middle East and Africa Autoimmune Disease Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • TABLE 105 Middle East and Africa Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 106 Middle East and Africa Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 107 Middle East and Africa Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 108 Middle East and Africa Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 109 South Africa Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 110 South Africa Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 111 South Africa Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 112 South Africa Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 113 Saudi Arabia Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 114 Saudi Arabia Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 115 Saudi Arabia Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 116 Saudi Arabia Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 117 UAE Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD Million)
  • TABLE 118 UAE Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 119 UAE Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 120 UAE Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • TABLE 121 Kuwait Autoimmune Disease Diagnostics Market, by Type, 2021 - 2033 (USD)
  • TABLE 122 Kuwait Autoimmune Disease Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • TABLE 123 Kuwait Autoimmune Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • TABLE 124 Kuwait Autoimmune Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • FIG. 1 Market Research Process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Autoimmune Disease Diagnostics Market Segmentation
  • FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 11 Penetration & Growth Prospect Mapping
  • FIG. 12 Swot Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Autoimmune Disease Diagnostics Market: Type Outlook and Key Takeaways
  • FIG. 15 Autoimmune Disease Diagnostics Market: Type Movement Analysis & Market Share 2024 & 2030
  • FIG. 16 Implementation Of the Amp Ra/SLE Program, By Research Phase
  • FIG. 17 Global Systemic Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 18 Global Rheumatoid Arthritis Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 19 Global Ankylosing Spondylitis Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 20 Global Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 21 Global Other Systemic Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 22 Global Localized Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 23 Global Multiple Sclerosis Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 24 Global Type 1 Diabetes Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 25 Global Hashimoto's Thyroiditis Diagnostics Market, 2013 - 2025 (USD Millio2021 - 2033 (USD Million)
  • FIG. 26 Global Idiopathic Thrombocytopenic Purpura Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 27 Global Other Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 28 Autoimmune Disease Diagnostics Market: Product Outlook and Key Takeaways
  • FIG. 29 Autoimmune Disease Diagnostics Market: Product Movement Analysis & Market Share
  • FIG. 30 Global Instruments Market, 2021 - 2033 (USD Million)
  • FIG. 31 Global Consumables and Assays Tests Market, 2021 - 2033 (USD Million)
  • FIG. 32 Autoimmune Disease Diagnostics Market: Test Outlook and Key Takeaways
  • FIG. 33 Autoimmune Disease Diagnostics Market: Test Movement Analysis & Market Share
  • FIG. 34 Global Antinuclear Antibody Tests Market, 2021 - 2033 (USD Million)
  • FIG. 35 Global Autoantibody Tests Market, 2021 - 2033 (USD Million)
  • FIG. 36 Global C-Reactive Protein (CRP) Market, 2021 - 2033 (USD Million)
  • FIG. 37 Global Complete Blood Count (CBC) Market, 2021 - 2033 (USD Million)
  • FIG. 38 Global Urinalysis Market, 2021 - 2033 (USD Million)
  • FIG. 39 Global Others Market, 2021 - 2033 (USD Million)
  • FIG. 40 Autoimmune Disease Diagnostics Market: End Use Outlook and Key Takeaways
  • FIG. 41 Autoimmune Disease Diagnostics Market: End Use Movement Analysis & Market Share
  • FIG. 42 Global Hospitals Market, 2021 - 2033 (USD Million)
  • FIG. 43 Global Diagnostic Centres Market, 2021 - 2033 (USD Million)
  • FIG. 44 Global Others Market, 2021 - 2033 (USD Million)
  • FIG. 45 Regional Marketplace: Key Takeaways
  • FIG. 46 Regional Outlook, 2024 & 2030
  • FIG. 47 Regional Market Dashboard
  • FIG. 48 Regional Market Place: Key Takeaways
  • FIG. 49 North America, Swot Analysis
  • FIG. 50 Europe, Swot Analysis
  • FIG. 51 Asia Pacific, Swot Analysis
  • FIG. 52 Latin America, Swot Analysis
  • FIG. 53 Middle East and Africa, Swot Analysis
  • FIG. 54 North America
  • FIG. 55 North America Autoimmune Disease Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • FIG. 56 U.S. Key Country Dynamics
  • FIG. 57 U.S. America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 58 Canada Key Country Dynamics
  • FIG. 59 Canada America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 60 Mexico Key Country Dynamics
  • FIG. 61 Mexico America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 62 Europe America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 63 UK Key Country Dynamics
  • FIG. 64 UK America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 65 Germany Key Country Dynamics
  • FIG. 66 Germany America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 67 France Key Country Dynamics
  • FIG. 68 France America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 69 Italy Key Country Dynamics
  • FIG. 70 Italy America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 71 Spain Key Country Dynamics
  • FIG. 72 Spain America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 73 Sweden Key Country Dynamics
  • FIG. 74 Sweden America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 75 Norway Key Country Dynamics
  • FIG. 76 Norway America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 77 Denmark Key Country Dynamics
  • FIG. 78 Denmark America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 79 Asia Pacific America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 80 Japan Key Country Dynamics
  • FIG. 81 Japan America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 82 China Key Country Dynamics
  • FIG. 83 China America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 84 India Key Country Dynamics
  • FIG. 85 India America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 86 Australia Key Country Dynamics
  • FIG. 87 Australia America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 88 Thailand Key Country Dynamics
  • FIG. 89 Thailand America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 90 South Korea Key Country Dynamics
  • FIG. 91 South Korea America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 92 Latin America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 93 Brazil Key Country Dynamics
  • FIG. 94 Brazil America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 95 Argentina Key Country Dynamics
  • FIG. 96 Argentina America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 97 Middle East and Africa America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 98 South Africa Key Country Dynamics
  • FIG. 99 South Africa America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 100 Saudi Arabia Key Country Dynamics
  • FIG. 101 Saudi Arabia America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 102 UAE Key Country Dynamics
  • FIG. 103 UAE America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 104 Kuwait Key Country Dynamics
  • FIG. 105 Kuwait America Autoimmune Disease Diagnostics Market, 2021 - 2033 (USD Million)
  • FIG. 106 Strategy Mapping
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!